Hyaluronidase synthase 3 ( HAS3 ) variant and anthracycline-related cardiomyopathy: A report from the Children’s Oncology Group. Article

Sun, Can-Lan, Wang, Xuexia, Liu, Wei et al. (2013). Hyaluronidase synthase 3 ( HAS3 ) variant and anthracycline-related cardiomyopathy: A report from the Children’s Oncology Group. . JOURNAL OF CLINICAL ONCOLOGY, 31(15_suppl), 10004-10004. 10.1200/jco.2013.31.15_suppl.10004

cited authors

  • Sun, Can-Lan; Wang, Xuexia; Liu, Wei; Armenian, Saro; Hankonarson, Hakon; Hageman, Lindsey; Ding, Yan; Landier, Wendy; Keller, Frank G; Neglia, Joseph Philip; Desai, Sunil J; Sklar, Charles A; Castellino, Sharon M; Cherrick, Irene; Dreyer, Zoann; Yasui, Yutaka; Relling, Mary V; Bhatia, Smita

authors

publication date

  • May 20, 2013

published in

keywords

  • 2.1 Biological and endogenous factors
  • 32 Biomedical and Clinical Sciences
  • 3211 Oncology and Carcinogenesis
  • Cancer
  • Cardiovascular
  • Clinical Research
  • Genetics
  • Heart Disease
  • Pediatric
  • Pediatric Cancer
  • Prevention
  • Rare Diseases

Digital Object Identifier (DOI)

publisher

  • American Society of Clinical Oncology (ASCO)

start page

  • 10004

end page

  • 10004

volume

  • 31

issue

  • 15_suppl